Date : 30 July ,2020 Time : 9:30am Place : Virtual

The Diabetic retinopathy detection device, world’s first AI-powered device to receive US Food and Drug Administration approval. A signature project of ours for a US client turned out to be a great success that is helping many people today with their critical diabetic retinopathic situations. Mrs. Athira Sudhakar, our Lead Biostatistician has steered the helm for this project under the supervision of senior project manager Mrs. Limna Salim, and CEO Mr. Anoop P Ambika. This free webinar focused on a few unique statistical deliberations we had adapted to make this device ready for FDA approval. Today, this device has been used vastly across the USA to detect diabetic retinopathy diseases. If you wish to learn more about the topic AI-Powered Device to detect Diabetic Retinopathy OR advanced statistical deliberation we adapted, write to us at